GENE ONLINE|News &
Opinion
Blog

Cas9
Scribe Therapeutics Bags $100 Million in Series B to Advance CRISPR-Based Therapies
2021-04-01
New Cas9 Alternatives Give Mammoth Biosciences an Edge Over Other CRISPR companies
2020-10-25
CRISPR Pioneers Bag 2020 Nobel Prize in Chemistry
2020-10-07
Scientists Further Powerful Gene Editing Tech’s Caliber with Rapid, Low Cost COVID-19 Diagnosis
2020-09-06
Spotlight: New Hypercompact Megaphage Cas Enzyme (CasΦ) Shows Efficient Gene Editing
2020-08-16
CRISPR C-to-G Base Editors: A Therapeutic Promise
2020-07-31
Verve Therapeutic’s One Time Base Editing Treatment Cuts Down Cholesterol Levels in Blood
2020-06-30
Evolved Cas9 Facilitates CRISPR Access to Previously Unexplored Genomic Sites
2020-03-31
Jennifer Doudna Cofounded Mammoth Biosciences Bags $45M for CRISPR Based Diagnostics
2020-02-01
Broad Institute and Cyrus Biotech Join Hands to Develop Safe CRISPR
2019-12-05
Ignavibacterium Cas9 Beats Thermostability Record, Functions at 100 Degree Celsius
2019-11-14
The CRISPR-Cas9 Report Card
2018-06-14
LATEST
NDA for Biogen-Sage’s Zuranolone Accepted by FDA, Marking Another Step Forward in Depression Drug Development
2023-02-07
BMS Returns $475 Million Cancer Asset To Dragonfly Therapeutics
2023-02-07
FDA Expands Approval For Takeda’s Takhzyro To Prevent Hereditary Angioedema Attacks
2023-02-06
Abbott’s New Technologies for Arrhythmia Treatment Secure FDA and European Approval
2023-02-04
First Human Trial for Marburg Virus Vaccine Reports Success
2023-02-03
Karuna Licenses Goldfinch’s Mood Disorder Candidates For Potential $535 Million
2023-02-03
Novel Bioengineered Wearable Edgeless Skin Brings Hope to Revolutionize Plastic and Reconstructive Surgery
2023-02-03
Scroll to Top

Create an account with us now to say goodbye to all the pop-ups!